Survival after biventricular mechanical circulatory support: Does the type of device matter?

BACKGROUND: Biventricular support can be achieved using paracorporeal biventricular assist devices (BiVADs), the total artificial heart (TAH), and implantable VADs. This study evaluated the influence of the device on patient survival. METHODS: Data from 383 patients (321 men [84%]) undergoing primary, planned biventricular support using durable devices between 2000 and 2010 were extracted from the French multicentric Groupe de Reflexion sur l'Assistance Mecanique (GRAM) registry. Mean age was 41.6 +/- 14.0 years. Patients were classified as group 1, 255 (67%) with paracorporeal BiVADs; group 2, 90 (24%) with TAH; and group 3, 38 (10%) with implantable BiVADs. RESULTS: Mean patient support duration was 82.8 +/- 107.4 days and similar among groups (p = 0.53). Bridging to transplantation was successful in 211 patients (55%) and to recovery in 23 (6%). Mortality on device was similar among groups (p = 0.16). TAH patients had a significantly lower stroke rate (p < 0.0001). Actuarial estimates for survival while on support were 75.2% +/- 2.3%, 64.4% +/- 2.7%, 61.1% +/- 2.8%, and 56.8% +/- 3.1% at 30, 60, 90, and 180 days, respectively, and were similar among groups. However, TAH patients undergoing prolonged support (90 clays) showed a trend toward improved survival (p = 0.08). Actuarial post-transplant survival estimates were, respectively, 81.7 +/- 2.7, 75.3 +/- 3.0, 73.0 +/- 3.0, and 64.7 +/- 3.7 at 1 month and 1, 3, and 5 years and were similar among groups (p = 0.84). CONCLUSION: Survival while on support and after heart transplantation did not differ significantly in patients supported with paracorporeal BiVADs, implantable BiVADs, or the TAH. Patients undergoing prolonged support (>90 days) tended to have improved survival when supported with TAM compared with BiVADs, which may be related to a lower incidence of neurologic events. J Heart Lung Transplant 2012;31:501-8 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.